Back
Stoke Therapeutics 10K Form
Sell
35
STOK
Stoke Therapeutics
Last Price:
$8.15
Seasonality Move:
19.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive STOK News And Ratings
See the #1 stock for the next 7 days that we like better than STOK
STOK Financial Statistics
Sales & Book Value
| Annual Sales: | $36.6M |
|---|---|
| Cash Flow: | $-23.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.24 |
| Price / Book: | 1.97 |
Profitability
| EPS (TTM): | -1.68000 |
|---|---|
| Net Income (TTM): | $-89M |
| Gross Margin: | -- |
| Return on Equity: | -44.32% |
| Return on Assets: | -34.06% |
Stoke Therapeutics Earnings Forecast
Key Stoke Therapeutics Financial Ratios
-
The Research & Development expenses have been 243.83% of Revenue.
-
The Net Earning history of STOK is -243.42% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Stoke Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | STOK |
| CUSIP: | 86150R |
| Website: | stoketherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.81 |
| Quick Ratio: | 5.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
STOK Technical Analysis vs Fundamental Analysis
Sell
35
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a SellThe current Stoke Therapeutics [STOK] share price is $8.33. The Score for STOK is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.